Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A
NCT ID: NCT02362581
Last Updated: 2015-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2012-12-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study determines to compare the efficacy of prophylaxis and on-demand treatment in moderate to severe hemophilia A children in King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients
NCT02727647
Clinical Outcomes of Low Dose PK-guided EHL FVIII Concentrates Versus Standard Prophylaxis in Severe Haemophilia A
NCT05281185
A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A
NCT01233258
Prophylaxis Versus on Demand Treatment for Children With Hemophilia A
NCT01810666
Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A
NCT02256917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
On demand treatment, prophylaxis treatment
On demand treatment arm:Patients received factorVIII concentrate(Hemofil M) when they had bleeding episodes.
Prophylaxis arm: patients received factorVIII concentrate (Hemofil M) 30-35 unit/kg once a week
prophylaxis treatment, on demand treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prophylaxis treatment, on demand treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis severe and moderate hemophilia A
Exclusion Criteria
* No factor VIII inhibitor
6 Months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Darintr Sosothikul
Pediatric Hematology/Oncology department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Darintr Sosothikul, Asso professer
Role: PRINCIPAL_INVESTIGATOR
pediatric Hemato-Oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
pediatric Hemato-oncology department, King Chulalongkorn Memorial Hospital
Pratumwan, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3125055
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.